Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Virtus Convertible And Income Fund | NCV-A | Jan 17, 2025 | 21.22 | +0.14 |
Virtus Convertible And Income Fund II | NCZ-A | Jan 17, 2025 | 20.49 | +0.10 |
Virtus Dividend Interest & Premium Strategy Fund | NFJ | Jan 17, 2025 | 12.86 | +0.39 |
Virtus Equity & Convertible Income Fund | NIE | Jan 17, 2025 | 24.65 | -0.08 |
Virtus Global Multisector Income Fund | VGI | Jan 17, 2025 | 7.68 | +0.26 |
Virtus Investment Partners | VRTS | Jan 17, 2025 | 210.08 | -0.43 |
Virtus Stone Harbor Emerging Markets Fund | EDF | Jan 17, 2025 | 5.00 | -0.60 |
Virtus Total Return Fund | ZTR | Jan 17, 2025 | 5.97 | +1.53 |
Visa | V | Jan 17, 2025 | 319.62 | +0.75 |
Vishay Intertechnology | VSH | Jan 17, 2025 | 16.50 | -0.06 |
Vishay Precision Group | VPG | Jan 17, 2025 | 22.73 | -2.57 |
Vision Marine Technologies | VMAR | Jan 17, 2025 | 1.91 | +4.37 |
Visionary Holdings | GV | Jan 17, 2025 | 2.25 | +0.90 |
Vislink Technologies | VISL | Jan 17, 2025 | 3.80 | -4.52 |
Vista Gold | VGZ | Jan 17, 2025 | 0.57 | +1.21 |
Vista Oil & Gas A ADR | VIST | Jan 17, 2025 | 56.73 | -2.74 |
Vistagen Therapeutics | VTGN | Jan 17, 2025 | 2.92 | 0.00 |
Visteon | VC | Jan 17, 2025 | 84.03 | -0.31 |
Vistra | VST | Jan 17, 2025 | 170.86 | -1.80 |
Vita Coco | COCO | Jan 17, 2025 | 34.60 | -0.29 |
Vital Energy | VTLE | Jan 17, 2025 | 35.94 | -1.62 |
Vital Farms | VITL | Jan 17, 2025 | 45.01 | +4.33 |
Vitesse Energy | VTS | Jan 17, 2025 | 27.35 | +0.37 |
Vivakor | VIVK | Jan 17, 2025 | 1.03 | +0.53 |
Vivani Medical | VANI | Jan 17, 2025 | 1.20 | -0.83 |
Vivid Seats A | SEAT | Jan 17, 2025 | 4.78 | -1.44 |
VivoPower International | VVPR | Jan 17, 2025 | 1.13 | -5.04 |
Vivos Therapeutics | VVOS | Jan 17, 2025 | 5.74 | -3.53 |
Vizio A | VZIO | Jan 17, 2025 | 11.35 | 0.00 |
Vizsla Silver | VZLA | Jan 17, 2025 | 1.92 | -1.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.